☆ 4.6 Article

COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital

JOURNAL OF FUNGI (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes et al.

Summary: Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a common complication among critically ill COVID-19 patients in ICU. It is more prevalent in older patients, those receiving invasive ventilation, and those receiving tocilizumab treatment. CAPA is an independent predictor of ICU mortality.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Article Immunology

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

Emily C. Somers et al.

Summary: In mechanically ventilated COVID-19 patients, the use of IL-6 blockade with tocilizumab was associated with lower mortality despite higher occurrence of superinfections.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study

Michele Bartoletti et al.

Summary: The study showed a high incidence of CAPA among critically ill COVID-19 patients, and its occurrence seems to alter the natural course of the disease.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Respiratory System

Can SARS-CoV-2 be a Risk Factor for Pulmonary Aspergillosis?

Marta Garcia Clemente et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

添加到收藏夹

Editorial Material Respiratory System

Influenza, SARS-CoV-2 and Invasive Pulmonary Aspergillosis

Marta Garcia Clemente et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

添加到收藏夹

Article Immunology

Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study

Jeffrey D. Jenks et al.

Summary: The study demonstrated that the Aspergillus Galactomannan Lateral Flow Assay showed good diagnostic performance for invasive aspergillosis, and its performance was consistent across different patient cohorts and centers.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Editorial Material Immunology

Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores

Martin Hoenigl

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit

P. Lewis White et al.

Summary: Invasive fungal disease is common in critically ill COVID-19 patients, with 26.7% incidence rate including 14.1% aspergillosis and 12.6% yeast infections. Mortality rates are reduced with antifungal therapy, while corticosteroid use and history of chronic respiratory disease increase the likelihood of aspergillosis. Strategic diagnostic screening and antifungal prophylaxis may enhance the management of COVID-19 patients.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Dermatology

Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study

Philipp Koehler et al.

Summary: Through simulation experiments, it was found that there is extensive aerosol generation, droplet spread, and surface contamination during bronchoscopy. By repurposing covers for ultrasound transducers or endoscopic cameras to seal the tube opening during bronchoscopy in mechanically ventilated patients, exposure of health-care workers and surface contamination can be efficiently reduced.

MYCOSES (2021)

添加到收藏夹

Article Critical Care Medicine

Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU

Arnaud Fekkar et al.

Summary: This study examined the occurrence of invasive fungal respiratory superinfections in severe COVID-19 patients admitted to five ICUs in France, finding that patients with no underlying immunosuppression seem at low risk of invasive fungal secondary infection.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort

Sarah Delliere et al.

Summary: Invasive pulmonary aspergillosis (IPA) is a relatively common complication in severe COVID-19 patients, leading to increased mortality. Treatment with azithromycin for >= 3 days is associated with higher risk of developing probable IPA, while high-dose dexamethasone may also play a role in IPA occurrence.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Dermatology

Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia

Gonzalo Segrelles-Calvo et al.

Summary: As the COVID-19 pandemic continues to spread globally, the risk of invasive fungal infections as a coinfection poses a significant threat to severely ill patients. Larger cohort studies are necessary to investigate the impact of COVID-19 immunosuppressive therapy on the development of aspergillosis.

MYCOSES (2021)

添加到收藏夹

Review Dermatology

Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

Marina Machado et al.

Summary: COVID-19-associated pulmonary aspergillosis is a serious and potentially life-threatening complication in severe COVID-19 patients, especially those receiving corticosteroids. Mortality rate in reviewed cases is high at 56.3%.

MYCOSES (2021)

添加到收藏夹

Letter Infectious Diseases

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis reply

Kauser Jabeen et al.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis

Kauser Jabeen et al.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Dermatology

COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series

Eelco F. J. Meijer et al.

Summary: CAPA has emerged as an invasive fungal disease affecting previously immunocompetent, mechanically ventilated ICU patients with high mortality. This study found a significant decrease in the number of COVID-19 patients needing mechanical ventilation in the ICU during the second wave, but a slightly higher percentage were diagnosed with CAPA. The use of dexamethasone did not show significant impact on CAPA incidence or mortality rates.

MYCOSES (2021)

添加到收藏夹

Review Immunology

Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis

Frederic Lamoth et al.

Summary: Invasive pulmonary aspergillosis is increasingly recognized as a life-threatening complication of severe respiratory viral infections, such as influenza, and concerns have been raised about its potential complicating COVID-19 in ICU patients. Differences in diagnostic strategies, definitions, and local factors may contribute to the variable incidence of this complication. The distinction between COVID-19-associated pulmonary aspergillosis (CAPA) and influenza-associated pulmonary aspergillosis (IAPA) lies in the majority of CAPA cases being classified as putative rather than proven/probable IPA, and the discrepancies can possibly be explained by the distinct physiopathology of influenza and COVID-19.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Dermatology

Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches

Jeffrey D. Jenks et al.

Summary: This review focuses on the epidemiology, definitions, diagnostic tests, clinical presentation, and imaging findings of invasive aspergillosis (IA) in critically ill patients in the intensive care unit, providing direction for further research.

MYCOSES (2021)

添加到收藏夹

Letter Critical Care Medicine

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges

Juergen Prattes et al.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Article Microbiology

Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients

Mehmet Ergun et al.

Summary: Literature on COVID-19-associated pulmonary aspergillosis has conflicting observations, with some CAPA patients surviving without antifungal therapy and discrepancies between CAPA diagnosis and autopsy findings. A case-control study was conducted comparing Aspergillus test profiles in CAPA patients and controls. The study showed that positive serum GM and BDG were associated with increased mortality in CAPA patients, highlighting the need for biomarkers to differentiate between respiratory tract colonization and tissue-invasive CAPA disease.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Aspergillus in Critically Ill COVID-19 Patients: A Scoping Review

Erlangga Yusuf et al.

Summary: Several studies have reported varying proportions of Aspergillus findings in COVID-19 patients, with most studies not explicitly mentioning radiographic findings. Respiratory samples were usually obtained to investigate clinical deterioration, with a range of testing methods such as culture, antigen, or PCR used.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Immunology

COVID-19-Associated Pulmonary Aspergillosis, March-August 2020

Jon Salmanton-Garcia et al.

Summary: This study found that most patients with coronavirus disease-associated pulmonary aspergillosis (CAPA) are diagnosed shortly after admission, with the majority being treated in the ICU. Azole-resistant strains of Aspergillus fumigatus were common in patients, and voriconazole was the main treatment choice. The overall mortality rate was approximately 52.2%, with about one third of deaths attributed to CAPA.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Aspergillosis Complicating Severe Coronavirus Disease

Kieren A. Marr et al.

Summary: The syndromes of pulmonary aspergillosis complicating severe viral infections are distinct from classic invasive aspergillosis, which is recognized most frequently in persons with neutropenia and in other immunocompromised persons.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Respiratory System

Invasive Aspergillosis as a Complication of Influenza Virus H3N2 Infection

Marta Garcia Clemente et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2020)

添加到收藏夹

Article Immunology

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Peter Donnelly et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Infectious Diseases

High -volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum

P. Vergidis et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

添加到收藏夹

Letter Critical Care Medicine

COVID-19-associated Pulmonary Aspergillosis

Andreas L. E. van Arkel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

添加到收藏夹

Article Critical Care Medicine

The Use of Bronchoscopy During the Coronavirus Disease 2019 Pandemic CHEST/AABIP Guideline and Expert Panel Report

Momen M. Wahidi et al.

CHEST (2020)

添加到收藏夹

Article Immunology

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

Chuan Qin et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Review Virology

Coronavirus disease 2019: What we know?

Feng He et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Letter Critical Care Medicine

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

Alexandre Alanio et al.

LANCET RESPIRATORY MEDICINE (2020)

添加到收藏夹

Article Dermatology

COVID-19 associated pulmonary aspergillosis

Philipp Koehler et al.

MYCOSES (2020)

添加到收藏夹

Review Critical Care Medicine

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

Paul E. Verweij et al.

INTENSIVE CARE MEDICINE (2020)

添加到收藏夹

Article Immunology

Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19

George R. Thompson et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Microbiology

Is the COVID-19 Pandemic a Good Time to IncludeAspergillusMolecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience

Jean-Pierre Gangneux et al.

JOURNAL OF FUNGI (2020)

添加到收藏夹

Review Microbiology

COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment

Amir Arastehfar et al.

JOURNAL OF FUNGI (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Detection of Unsuspected Coronavirus Disease 2019 Cases by Computed Tomography and Retrospective Implementation of the Radiological Society of North America/Society of Thoracic Radiology/American College of Radiology Consensus Guidelines

Min Lang et al.

JOURNAL OF THORACIC IMAGING (2020)

添加到收藏夹

Letter Medicine, General & Internal

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Catherine F. Houlihan et al.

LANCET (2020)

添加到收藏夹

Article Critical Care Medicine

Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series

Antine W. Flikweert et al.

JOURNAL OF CRITICAL CARE (2020)

添加到收藏夹

Review Infectious Diseases

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Philipp Koehler et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Microbiology

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods

A. Espinel-Ingroff et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Dermatology

Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage

Jeffrey D. Jenks et al.

MYCOSES (2019)

添加到收藏夹

Article Critical Care Medicine

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

Alexander F. A. D. Schauwvlieghe et al.

LANCET RESPIRATORY MEDICINE (2018)

添加到收藏夹

Letter Critical Care Medicine

Influenza-associated Aspergillosis in Critically III Patients

Frank L. van de Veerdonk et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

添加到收藏夹

Article Respiratory System

Influenza virus-induced lung injury: pathogenesis and implications for treatment

Susanne Herold et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

添加到收藏夹

Article Microbiology

Performance of Galactomannan, Beta-D-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

M. Hoenigl et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2014)

添加到收藏夹

Article Critical Care Medicine

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study

Joost Wauters et al.

INTENSIVE CARE MEDICINE (2012)

添加到收藏夹

Editorial Material Immunology

Invasive Aspergillosis Complicating Pandemic Influenza A (H1N1) Infection in Severely Immunocompromised Patients

Carolina Garcia-Vidal et al.

CLINICAL INFECTIOUS DISEASES (2011)

添加到收藏夹

Article Critical Care Medicine

Host adaptive immunity deficiency in severe pandemic influenza

Jesus F. Bermejo-Martin et al.

CRITICAL CARE (2010)

添加到收藏夹

Article Infectious Diseases

Invasive aspergillosis in glucocorticoid-treated patients

Russell E. Lewis et al.

MEDICAL MYCOLOGY (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.